Visceral adiposity index in patients with coronary artery disease, obesity and type 2 diabetes
Open Access
- 3 July 2020
- journal article
- research article
- Published by Silicea - Poligraf, LLC in Cardiovascular Therapy and Prevention
- Vol. 19 (3) , 2311
Abstract
Aim. To assess visceral adiposity index (VAI) in patients with coronary artery disease (CAD) and overweight or obesity, as well as to determine its relationship with lipid and carbohydrate metabolism parameters and inflammatory markers, depending on the presence of carbohydrate metabolism disorders (CMD).Material and methods. The study included 95 patients with CAD and overweight (body mass index (BMI) >25 kg/m2) or obesity (BMI >30 kg/m2), of which 59 patients had type 2 diabetes (T2D) and 36 were without CMD. All patients were assessed for obesity; VAI was calculated. Following laboratory parameters were evaluated: glucose, glycated hemoglobin, C-reactive protein, adiponectin, lipid panel. In patients without history of CMD, an oral glucose tolerance test was performed.Results. Compared with patients without CMD, subjects with T2D had significantly higher values of BMI, waist circumference, as well as the body fat percentage, area and volume of visceral adipose tissue estimated by computed tomography. Analysis of lipid profile, C-reactive protein and adiponectin levels did not reveal significant differences between the groups. VAI also did not significantly differ in both groups. VAI had the most correlations with clinical and metabolic parameters in both patients with T2D and without CMD. Other methods for assessing obesity were less correlated with laboratory parameters in both groups. Only VAI significantly correlated with adiponectin in both groups.Conclusion. The obtained correlations between VAI and clinical and metabolic parameters confirm the practicability of using it to determine adipose tissue dysfunction in patients with/without CMD. The effect of increased VAI on the cardiovascular risk in high-risk patients requires further study.Keywords
This publication has 13 references indexed in Scilit:
- The single use of body mass index for the obesity paradox is misleading and should be used in conjunction with other obesity indicesPostgraduate Medicine, 2019
- Advantages and disadvantages of different methods for diagnosis of visceral obesityObesity and metabolism, 2018
- Visceral adiposity index and 10-year cardiovascular disease incidence: The ATTICA studyNutrition, Metabolism and Cardiovascular Diseases, 2017
- Standards of specialized diabetes care. Edited by Dedov II, Shestakova MV, Mayorov AY. 8th editionDiabetes mellitus, 2017
- THE PREVALENCE OF NON-INFECTIOUS DISEASES RISK FACTORS IN RUSSIAN POPULATION IN 2012-2013 YEARS. THE RESULTS OF ECVD-RFCardiovascular Therapy and Prevention, 2014
- Visceral Adiposity Index (VAI) Is Predictive of an Altered Adipokine Profile in Patients with Type 2 DiabetesPLOS ONE, 2014
- OPPORTUNITIES FOR THE USE OF VISCERAL OBESITY INDEX IN METABOLIC SYNDROME DIAGNOSTICS AND PROGNOSIS OF ITS COMPLICATION RISKRussian Journal of Cardiology, 2014
- Overview of Epidemiology and Contribution of Obesity to Cardiovascular DiseaseProgress in Cardiovascular Diseases, 2014
- Association of All-Cause Mortality With Overweight and Obesity Using Standard Body Mass Index CategoriesJAMA, 2013
- Reduction in serum apoB is associated with reduced inflammation and insulin resistance in post-menopausal women: A MONET studyAtherosclerosis, 2010